This study is the first to quantify absolute plasma concentrations of LRG1, C9, SERPINA3, GSN, IGHA1, and APOA4 in GBM patients, and to show that their expression levels are significantly different (p < 0.05) from those in healthy controls. The gene discussed is GSN; the disease is glioblastoma.